Erin Henry, PhD
Executive Director, Head of Ophthalmology
NGM Biopharmaceuticals
Biography
Erin Henry, Ph.D. is the Executive Director of Clinical Research at NGM Bio. She currently oversees the NGM621 Clinical Development Program for Geographic Atrophy as the Project Team Leader and Clinical Lead. Previously, Erin worked at Genentech, Inc for 13 years in the Medical Affairs, Product Development and Marketing Ophthalmology Franchise. Erin completed a Ph.D. from Vanderbilt University in Neurobiology and a Post-doctoral Fellowship in the Department of Ophthalmology from Washington University in St. Louis.